Osnat Bartok
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Osnat Bartok has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Schaffer
Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, USA
55 shared publications - Ansuman T. Satpathy
Department of Pathology, School of Medicine, Stanford University, Palo Alto, USA
55 shared publications - Chen Weller
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
55 shared publications - Colin J. Raposo
Department of Pathology, Stanford University
55 shared publications - Dean Ranmar
Weizmann Institute of Science 5 Department of Life Sciences Core Facilities Rehovot, Israel
55 shared publications - Elizabeta Yakubovich
Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel
55 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Clinical data and characterization of the single-cell clones.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Clinical data and characterization of the single-cell clones.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 10 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
List of antibodies used for IHC staining of human samples.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 10 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
List of antibodies used for IHC staining of human samples.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 13 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
ScRNA-seq characterization of Mif KO tumor clones.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 13 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
ScRNA-seq characterization of Mif KO tumor clones.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Tables- legends from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Legends for the supplementary tables 1-10.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables- legends from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Legends for the supplementary tables 1-10.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 3 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Pathway enrichment in samples at day 0 post-inoculation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 3 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Pathway enrichment in samples at day 0 post-inoculation.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Rejection and non-rejection gene sets identified in the scRNA sequencing analysis can stratify patients with high/low ITH and hot/cold tumor annotations.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Rejection and non-rejection gene sets identified in the scRNA sequencing analysis can stratify patients with high/low ITH and hot/cold tumor annotations.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 4 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Pathway enrichment in samples at days 6, 10, 16, and 20 post-inoculation.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 4 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Pathway enrichment in samples at days 6, 10, 16, and 20 post-inoculation.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 9 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
CellChat and CellPhoneDB analyses reveal increased MIF signaling from tumor cells to macrophages in non-rejected clones.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 9 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
CellChat and CellPhoneDB analyses reveal increased MIF signaling from tumor cells to macrophages in non-rejected clones.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Opal and CODEX multiplexed tissue imaging data shows infiltration of proliferative CD8+ T-cells to the rejected SCCs.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
Opal and CODEX multiplexed tissue imaging data shows infiltration of proliferative CD8+ T-cells to the rejected SCCs.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
CyTOF analysis confirms high M2-like macrophage infiltration and T-cell exhaustion in non-rejected single-cell clones.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from Temporal Genomic Analysis of Homogeneous Tumor Models Reveals Key Regulators of Immune Evasion in Melanoma
CyTOF analysis confirms high M2-like macrophage infiltration and T-cell exhaustion in non-rejected single-cell clones.